首页> 外文期刊>Advances in BioResearch >Role of Endothelin-1 in Memory Loss
【24h】

Role of Endothelin-1 in Memory Loss

机译:内皮素-1在记忆丧失中的作用

获取原文
           

摘要

Endothelin (ET-1) is a 21 amino acid peptide produced by vascular endothelium from 39 amino acid precursor, big ET-1, through the actions of endothelin converting enzyme(ECE) present on the endothelial cell membrane.It is known that cerebral blood flow (CBF) as well as vascular functions are reduced in patients with Alzheimer's disease (AD) and this reduction occurs prior to the onset of dementia. The brain damage and memory disruptions that occur in AD are considered as a result of accumulation of a substance known as amyloid beta (Aβ) in the brain. Aβ increases the production of endothelin-1 (ET-1), by acting on endothelin converting enzyme-2 (ECE-2), which cleaves big endothelin resulting in the formation of ET-1 and Aβ-40. The triggered production of ET-1 in the lining of blood vessels of the brain causes them to constrict, narrowing their lumen,which reduces blood flow through the brain in patients with AD, and thereby deteriorate the oxygen and nutrients supply to nerve cells and slowdown the pace of removal of waste products, resulting to cause adverse effects on nerve cell function. The reduction in blood supply may increase the production of Aβ and thereby accelerate the progression of the AD. ET-1reduction in blood flow is achieved by targeting on specific endothelin receptors (ET A ) in the vessel walls. The down regulation of ET A receptor could be a possibility in maintaining CBF in AD and also emphasizing use of endothelin converting enzyme (ECE) as a novel Aβ degrading enzyme can reduce memory loss to an extent.
机译:内皮素(ET-1)是血管内皮细胞由39个氨基酸的前体大ET-1通过内皮细胞膜上存在的内皮素转化酶(ECE)的作用而产生的21个氨基酸的肽。阿尔茨海默氏病(AD)患者的血流量(CBF)和血管功能降低,并且这种降低发生在痴呆症发作之前。 AD中发生的脑损伤和记忆障碍被认为是由于大脑中称为淀粉样蛋白(Aβ)的物质蓄积的结果。 Aβ通过作用于内皮素转化酶2(ECE-2)来增加内皮素-1(ET-1)的产生,该酶裂解大的内皮素导致形成ET-1和Aβ-40。 ET-1在脑血管壁中的触发产生导致它们收缩,使管腔变窄,从而减少了AD患者大脑中的血流,从而恶化了向神经细胞的氧气和营养供应并减慢了速度清除废物的步伐,导致对神经细胞功能造成不利影响。血液供应的减少可能会增加Aβ的产生,从而加速AD的进展。通过靶向血管壁中的特定内皮素受体(ET A)来实现血流ET-1的减少。 ET A受体的下调可能是维持AD中CBF的一种可能,并且强调使用内皮素转化酶(ECE)作为一种新型的Aβ降解酶可以在一定程度上降低记忆力丧失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号